| Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
| In Search for a Haemoglobin Threshold in Myelodysplastic Syndromes |
|
British Journal of Haematology |
Myelodysplastic Syndromes (MDS) |
| Improvements in hematologic markers and decreases in fatigue with pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and mild or moderate anemia (hemoglobin ≥10 g/dL) who had received eculizumab or were naive to complement inhibitors |
|
PLOS One |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes |
|
Nature Medicine |
Myelodysplastic Syndromes (MDS) |
| Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria |
|
Leukemia |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients |
|
Leukemia |
Myelodysplastic Syndromes (MDS) |
| Impact of Mutational Landscape and Burden on RBC Transfusion Response in Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the COMMANDS Study |
|
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
| Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapy |
|
Blood Advances |
Aplastic Anemia |
| Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia |
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation |
Aplastic Anemia |
| Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia |
|
Bone Marrow Transplant |
Aplastic Anemia |
